{"id":"https://openalex.org/W1895234166","doi":"https://doi.org/10.18632/oncotarget.3504","title":"Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma","display_name":"Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma","alternate_titles":[],"publication_year":2015,"publication_date":"2015-03-10","ids":{"openalex":"https://openalex.org/W1895234166","doi":"https://doi.org/10.18632/oncotarget.3504","mag":"1895234166","pmid":"https://pubmed.ncbi.nlm.nih.gov/25844600","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4496350"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.3504","doi":"https://doi.org/10.18632/oncotarget.3504","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.3504","pdf_url":"https://www.oncotarget.com/article/3504/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1895234166"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.oncotarget.com/article/3504/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050562133","display_name":"Lindi Chen","orcid":"https://orcid.org/0000-0001-7223-4226","observed_orcids":["https://orcid.org/0000-0001-7223-4226","https://orcid.org/0000-0001-9802-530X"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lindi Chen","raw_affiliation_strings":["Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020286775","display_name":"Rapha\u00ebl F. Rousseau","orcid":"https://orcid.org/0000-0001-7288-5213","observed_orcids":["https://orcid.org/0000-0001-7288-5213"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rapha\u00ebl F. Rousseau","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112474366","display_name":"Steven A. Middleton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Steven A. Middleton","raw_affiliation_strings":["Hoffmann-La Roche Inc., Nutley, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., Nutley, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074661473","display_name":"GWEN L. NICHOLS","orcid":"https://orcid.org/0000-0002-3714-4927","observed_orcids":["https://orcid.org/0000-0002-3714-4927"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gwen L. Nichols","raw_affiliation_strings":["Hoffmann-La Roche Inc., Nutley, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hoffmann-La Roche Inc., Nutley, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112541341","display_name":"David R. Newell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David R. Newell","raw_affiliation_strings":["Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005245931","display_name":"John Lunec","orcid":"https://orcid.org/0000-0002-1878-8583","observed_orcids":["https://orcid.org/0000-0002-1878-8583"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Lunec","raw_affiliation_strings":["Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053438302","display_name":"Deborah A. Tweddle","orcid":"https://orcid.org/0000-0003-2208-3970","observed_orcids":["https://orcid.org/0000-0003-2208-3970"]},"institutions":[{"id":"https://openalex.org/I84884186","display_name":"Newcastle University","ror":"https://ror.org/01kj2bm70","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Deborah A. Tweddle","raw_affiliation_strings":["Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle, United Kingdom","institution_ids":["https://openalex.org/I84884186"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053438302"],"corresponding_institution_ids":["https://openalex.org/I84884186"],"apc_list":null,"apc_paid":{"value":3046,"currency":"EUR","value_usd":3285},"fwci":3.9667,"has_fulltext":true,"cited_by_count":82,"citation_normalized_percentile":{"value":0.95875328,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"6","issue":"12","first_page":"10207","last_page":"10221"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.8521000146865845,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.8521000146865845,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.14339999854564667,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.8090000152587891},{"id":"https://openalex.org/keywords/rg7388","display_name":"RG7388","score":0.9359999895095825},{"id":"https://openalex.org/keywords/mdm2-p53-antagonist","display_name":"MDM2-p53 antagonist","score":0.9200000166893005},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.777999997138977},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6869999766349792},{"id":"https://openalex.org/keywords/mycn","display_name":"MYCN","score":0.8109999895095825},{"id":"https://openalex.org/keywords/p14arf","display_name":"p14ARF","score":0.7829999923706055},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.765999972820282},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9819999933242798},{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.9750000238418579},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/busulfan","display_name":"busulfan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9350000023841858},{"id":"https://openalex.org/keywords/caspase-3-7","display_name":"caspase 3/7","score":0.9079999923706055},{"id":"https://openalex.org/keywords/neuroblastoma-cell-lines","display_name":"neuroblastoma cell lines","score":0.8130000233650208}],"concepts":[{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.8960316181182861},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6452956199645996},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.547064483165741},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.44016116857528687},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.43713656067848206},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4193943738937378},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.40157458186149597},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.35964345932006836},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32903560996055603},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.31201106309890747},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.19629275798797607},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14993447065353394},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09998127818107605},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001932","descriptor_name":"Brain Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051736","descriptor_name":"Proto-Oncogene Proteins c-mdm2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051736","descriptor_name":"Proto-Oncogene Proteins c-mdm2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D062366","descriptor_name":"para-Aminobenzoates","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D062366","descriptor_name":"para-Aminobenzoates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.18632/oncotarget.3504","doi":"https://doi.org/10.18632/oncotarget.3504","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.3504","pdf_url":"https://www.oncotarget.com/article/3504/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4496350","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4496350/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"},{"id":"pmid:25844600","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25844600","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"},{"id":"doi:10.25405/ncl.34247055","doi":"https://doi.org/10.25405/ncl.34247055","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34247055","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.25405/ncl.34247055.v1","doi":"https://doi.org/10.25405/ncl.34247055.v1","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34247055.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.3504","doi":"https://doi.org/10.18632/oncotarget.3504","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.3504","pdf_url":"https://www.oncotarget.com/article/3504/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4235175554","display_name":null,"funder_award_id":"11NCL05","funder_id":"https://openalex.org/F4320320345","funder_display_name":"Sparks"}],"funders":[{"id":"https://openalex.org/F4320306156","display_name":"Children's Cancer Research Fund","ror":"https://ror.org/02wv5fj21"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320320345","display_name":"Sparks","ror":"https://ror.org/02ez1f997"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1895234166.pdf","grobid_xml":"https://content.openalex.org/works/W1895234166.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W1972902214","https://openalex.org/W1978978593","https://openalex.org/W1991167758","https://openalex.org/W1993964347","https://openalex.org/W1996632098","https://openalex.org/W2005482984","https://openalex.org/W2007411604","https://openalex.org/W2016543925","https://openalex.org/W2022416218","https://openalex.org/W2024508589","https://openalex.org/W2027203760","https://openalex.org/W2028387032","https://openalex.org/W2063960043","https://openalex.org/W2070990294","https://openalex.org/W2072887414","https://openalex.org/W2080354412","https://openalex.org/W2080533553","https://openalex.org/W2088107605","https://openalex.org/W2093775600","https://openalex.org/W2097933346","https://openalex.org/W2098748257","https://openalex.org/W2099293745","https://openalex.org/W2100970398","https://openalex.org/W2107418471","https://openalex.org/W2111637352","https://openalex.org/W2114514966","https://openalex.org/W2124857275","https://openalex.org/W2130314846","https://openalex.org/W2144209664","https://openalex.org/W2151041413","https://openalex.org/W2152130005","https://openalex.org/W2154563079","https://openalex.org/W2155906069","https://openalex.org/W2167147606","https://openalex.org/W2323832138","https://openalex.org/W2327054845","https://openalex.org/W2346745996","https://openalex.org/W2508895628","https://openalex.org/W6649505896"],"related_works":["https://openalex.org/W2789884400","https://openalex.org/W2943883501","https://openalex.org/W7221548466","https://openalex.org/W2055398700","https://openalex.org/W2460318004","https://openalex.org/W1813521438","https://openalex.org/W2107418471","https://openalex.org/W2905275949","https://openalex.org/W2913881018","https://openalex.org/W2726242674"],"abstract_inverted_index":{"//":[0,68],"Lindi":[1],"Chen":[2],"1":[3,23,27,32,33],",":[4,9,14,19,24,168],"Rapha\u00ebl":[5],"F.":[6],"Rousseau":[7],"2":[8,47],"Steven":[10],"A.":[11,30,65],"Middleton":[12],"3":[13,18,55],"Gwen":[15],"L.":[16],"Nichols":[17],"David":[20],"R.":[21],"Newell":[22],"John":[25],"Lunec":[26],"and":[28,102,134,160,170,190,239,273,288],"Deborah":[29,64],"Tweddle":[31],"Newcastle":[34,42],"Cancer":[35,40],"Centre,":[36],"Northern":[37],"Institute":[38],"for":[39,110,202,283],"Research,":[41],"University,":[43],"Newcastle,":[44],"United":[45],"Kingdom":[46],"Genentech":[48],"Inc.,":[49,58],"South":[50],"San":[51],"Francisco,":[52],"CA,":[53],"USA":[54,61],"Hoffmann-La":[56],"Roche":[57],"Nutley,":[59],"NJ,":[60],"Correspondence":[62],"to:":[63],"Tweddle,":[66],"email:":[67],"Keywords":[69],":":[70,79,84,89],"neuroblastoma,":[71],"MDM2-p53":[72,103],"antagonists,":[73],"RG7388,":[74],"combination":[75,136,244],"therapy,":[76],"Calcusyn":[77],"Received":[78],"December":[80],"17,":[81,86],"2014":[82],"Accepted":[83],"February":[85],"2015":[87,92],"Published":[88],"March":[90],"10,":[91],"Abstract":[93],"Neuroblastoma":[94],"is":[95,115,266],"a":[96,106,132,145,194,280],"predominantly":[97],"p53":[98,290],"wild-type":[99],"(wt)":[100],"tumour":[101],"antagonists":[104],"offer":[105],"novel":[107,281],"therapeutic":[108],"strategy":[109],"neuroblastoma":[111,143,148,162,227,271,287],"patients.":[112],"RG7388":[113,130,151,198,216,233,265],"(Roche)":[114],"currently":[116,139],"undergoing":[117],"early":[118],"phase":[119],"clinical":[120],"evaluation":[121,278],"in":[122,135,144,157,197,224],"adults.":[123],"This":[124],"study":[125],"assessed":[126],"the":[127,185],"efficacy":[128],"of":[129,147,165,182,187,232],"as":[131,250,279],"single-agent":[133],"with":[137,175,218,234,285],"chemotherapies":[138],"used":[140],"to":[141,215,247,257,291],"treat":[142],"panel":[146],"cell":[149,163,206,228],"lines.":[150,207],"GI":[152,199],"50":[153,200],"concentrations":[154,201],"were":[155,211,241],"determined":[156],"21":[158],"p53-wt":[159,203,226,270],"mutant":[161,205],"lines":[164],"varying":[166],"MYCN":[167],"MDM2":[169],"p14":[171],"ARF":[172],"status,":[173],"together":[174],"MYCN-regulatable":[176],"Tet21N":[177,208],"cells.":[178,220],"The":[179],"primary":[180],"determinant":[181],"response":[183],"was":[184,193],"presence":[186],"wt":[188,289],"p53,":[189],"overall":[191],"there":[192],">200-fold":[195],"difference":[196],"versus":[204],"MYCN+":[209],"cells":[210],"significantly":[212],"more":[213],"sensitive":[214],"compared":[217,256],"MYCN-":[219],"Using":[221],"median-effect":[222],"analysis":[223],"5":[225],"lines,":[229],"selected":[230],"combinations":[231],"cisplatin,":[235],"doxorubicin,":[236],"topotecan,":[237],"temozolomide":[238],"busulfan":[240],"synergistic.":[242],"Furthermore,":[243],"treatments":[245],"led":[246],"increased":[248],"apoptosis,":[249],"evident":[251],"by":[252],"higher":[253],"caspase-3/7":[254],"activity":[255],"either":[258],"agent":[259],"alone.":[260],"These":[261],"data":[262],"show":[263],"that":[264],"highly":[267],"potent":[268],"against":[269],"cells,":[272],"strongly":[274],"supports":[275],"its":[276],"further":[277],"therapy":[282],"patients":[284],"high-risk":[286],"potentially":[292],"improve":[293],"survival":[294],"and/or":[295],"reduce":[296],"toxicity.":[297]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1895234166","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":16},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
